Citadel Advisors’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.22M Buy
93,600
+35,400
+61% +$2.58M ﹤0.01% 4103
2026
Q1
$3.8M Buy
58,200
+30,900
+113% +$2.3M ﹤0.01% 4809
2025
Q4
$2.16M Sell
27,300
-105,375
-79% -$8.07M ﹤0.01% 5751
2025
Q3
$9.69M Sell
132,675
-40,475
-23% -$2.97M ﹤0.01% 3326
2025
Q2
$13.1M Sell
173,150
-29,200
-14% -$2.07M ﹤0.01% 2675
2025
Q1
$15.4M Sell
202,350
-30,225
-13% -$2.25M ﹤0.01% 2328
2024
Q4
$15.4M Sell
232,575
-79,375
-25% -$5.56M ﹤0.01% 2454
2024
Q3
$21.7M Sell
311,950
-2,850
-0.9% -$171K ﹤0.01% 1961
2024
Q2
$16.6M Buy
+314,800
New +$19.1M ﹤0.01% 2188

Other funds holding SOLV

Citadel Advisors's SOLV Position: Q2 2026 in Review

Citadel Advisors reduced its Solventum (SOLV) stake by 84% in Q2 2026, selling an estimated $36.5M and leaving 98,232 shares worth $7.58M. The position accounts for ﹤0.01% of the portfolio, ranked #4019.

Citadel Advisors first reported a position in SOLV in Q1 2024 and has held it in 9 quarters since. The position peaked at $114M in Q3 2025. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Citadel Advisors held 98,232 shares of Solventum worth $7.58M as of Q2 2026.
  • Citadel Advisors sold 500,846 Solventum shares in Q2 2026, an estimated $36.5M.
  • Solventum made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4019 holding.
  • Citadel Advisors first reported a position in Solventum in Q1 2024 and has held it in 9 quarters since.
  • Citadel Advisors's Solventum position peaked at $114M in Q3 2025.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.